BACKGROUND: Platinum-based chemotherapy is standard-of-care first-line treatment for advanced urothelial carcinoma. However, progression-free survival and overall survival are limited by chemotherapy resistance. METHODS: In a phase 3 trial, we randomly assigned patients with unresectable locally adv...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!